Testing Status of Transgenic Model Evaluation (2,3,7,8-Tetrachlorodibenzodioxin) M950087
CASRN: 1746-01-6
Formula: C12-H4-Cl4-O2
Synonyms/Common Names
- TCDD
- 2,3,7,8-Tetrachlorodibenzo(b,e)(1,4)dioxin (9CI)
- 2,3,7,8-Tetrachlorodibenzo-1,4-dioxin
- 2,3,7,8-Tetrachlorodibenzodioxin (Transgenic model evaluation)
Short-Term Toxicity
- 25 weeks (Topical Application)
(C95007O)
Completed
- Mice: Tg.AC (FVB/N) Hemizygous
- Dose: 0 OR 0.166 UG/KG; 15/SEX/DOSE -- 3 TIMES PER WEEK.
- 25 weeks (Gavage)
(C95007P)
Completed
- Mice: P53 +/- (C57BL/6)
- Dose: M: 0 OR 0.25 UG/KG F: 0 OR 1.0 UG/KG; 15/SEX/DOSE -- 2 TIMES PER WEEK.
- 26 weeks (Gavage)
(C97012A)
Completed
- Mice: Tg.AC (FVB/N) Hemizygous
- Dose: FM: 0, 105, 450, OR 1250 NG/KG/DAY; 20/DOSE (5 DAYS PER WEEK).
- 26 weeks (Topical Application)
(C97012B)
Completed
- Mice: Tg.AC (FVB/N) Hemizygous
- Dose: FM: 0, 5, 17, 36, 76, 121, 166, 355, OR 760 NG/KG; 20/DOSE (3X PER WEEK).